Insulin-Like Growth Factor-1 Receptor Expression and Disease Recurrence and Survival in Patients with Resected Pancreatic Ductal Adenocarcinoma.
Chunxia DuAnnacarolina F L Da SilvaVicente Morales-OyarvideAndressa Dias CostaMargaret M KozakRichard F DunneDouglas A RubinsonKimberly PerezYohei MasugiTsuyoshi HamadaLauren K BraisChen YuanAna BabicMatthew D DucarAaron R ThornerAndrew AguirreMatthew H KulkeKimmie NgThomas E ClancyJennifer J Findeis-HoseyDaniel T ChangJason L HornickCharles S FuchsShuji OginoAlbert C KoongAram F HezelBrian M WolpinJonathan A NowakPublished in: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (2020)
IGF1R expression in PDAC represents a potential biomarker to guide patient selection for more aggressive, multidrug regimens in the adjuvant setting.